Viewing StudyNCT00263588



Ignite Creation Date: 2024-05-05 @ 12:10 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00263588
Status: COMPLETED
Last Update Posted: 2019-12-12
First Post: 2005-12-02

Brief Title: Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Neoplasms Breast
Keywords:
Name View
GW572016 View
breast cancer View
brain metastases View
ErbB2 positive View
HER2 positive View
neoplasms View
cancer View
lapatinib View
LAP016A2202 View
LAP016A View
CLAP016A2202 View